Celecoxib + Placebo
Phase 2Completed 0 watching 0 views this week⚡ Active
51
Development Stage
✓
Pre-clinical✓
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Colorectal Adenoma
Conditions
Colorectal Adenoma, Colorectal Carcinoma
Trial Timeline
Dec 1, 2001 → Jun 1, 2008
NCT ID
NCT00582660About Celecoxib + Placebo
Celecoxib + Placebo is a phase 2 stage product being developed by Pfizer for Colorectal Adenoma. The current trial status is completed. This product is registered under clinical trial identifier NCT00582660. Target conditions include Colorectal Adenoma, Colorectal Carcinoma.
Hype Score Breakdown
Clinical
17
Activity
12
Company
9
Novelty
5
Community
5
Clinical Trials (11)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01186887 | Pre-clinical | Completed |
| NCT00583453 | Phase 2 | Completed |
| NCT00359151 | Approved | Terminated |
| NCT00585312 | Phase 3 | Terminated |
| NCT00300729 | Phase 3 | UNKNOWN |
| NCT00640627 | Approved | Completed |
| NCT00698204 | Phase 2 | Completed |
| NCT00639483 | Phase 2 | Completed |
| NCT00471341 | Approved | Completed |
| NCT00582660 | Phase 2 | Completed |
| NCT02840162 | Phase 2 | Terminated |
Competing Products
20 competing products in Colorectal Adenoma